NEW ASSOCIATION BETWEEN 4-{3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL]PROPOXY}BENZAMIDE AND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
The present invention relates to an associated body of 4-{3-(cis-hexahydrocyclopenta(c)pyrrole-2(1H)-yl)propoxy}benzamide denoted by chemical formula I, or an additional salt thereof with pharmaceutically acceptable acid or base and an acetylcholinesterase inhibitor； and a medicine. [Reference numerals] (AA) Experimental Procedure(Tronche et al., transformed after 2010 )；(BB) Food；(CC) No fodd；(DD) Contextual serial discrimination test；(EE) Two consecutive；(FF) Discrimination；(GG) Two different context；(HH,SS) Treatment；(II,TT) Room C；(JJ,UU) Inject compound or carrier；(KK) Learn；(LL,OO,WW) Room A；(MM,PP) Hole with bait；(NN) Room B；(QQ) Length of stay；(RR) Animal quarters；(VV) Test；(XX) Correct response；(YY) Mistake；(ZZ) Interference response본 발명은 하기 화학식(I)의 4-{3-[시스-헥사하이드로시클로펜타[c]피롤-2(1H)-일]프로폭시}벤즈아미드 또는 약제학적으로 허용되는 산 또는 염기와의 이의 부가염과 아세틸콜린에스테라제 억제제의 회합체 및 의약에 관한 것이다:
